ScholarIQanswers from OpenAlex
Takeda Pharmaceuticals North America
FunderResearch funding and supported work
Takeda Pharmaceuticals North America is a funder indexed in ScholarIQ from OpenAlex.
What is known about Takeda Pharmaceuticals North America?
ScholarIQrecord summary
business enterprise in United States of America
How many works does Takeda Pharmaceuticals North America have?
ScholarIQindexed works
Takeda Pharmaceuticals North America has 422 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Takeda Pharmaceuticals North America?
ScholarIQopenalex
The OpenAlex for Takeda Pharmaceuticals North America is on the source record.
What is the ROR of Takeda Pharmaceuticals North America?
ScholarIQror
The ROR for Takeda Pharmaceuticals North America is on the source record.
What are the most-cited papers on Takeda Pharmaceuticals North America?
ScholarIQmost cited works
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
Bertram Pitt, Lars Køber, Piotr Ponikowski, Mihai Gheorghiade, Gerasimos Filippatos, Henry Krum, Christina Nowack, Peter Kolkhof, So Young Kim, Faı̈ez Zannad